Biora Therapeutics Inc (BIOR) is higher by 3.00% Monday In Premarket Trading

Biora Therapeutics Inc (BIOR) has risen Monday morning, with the stock gaining 3.00% in pre-market trading to 1.03. BIOR's short-term technical score of 42 indicates that the stock has traded less bullishly over the last month than 58% of stocks on the market. In the Biotechnology industry, which ranks 112 out of 146 industries, BIOR ranks higher than 51% of stocks. Biora Therapeutics Inc has risen 42.86% over the past month, closing at $0.69 on July 18. During this period of time, the stock fell as low as $0.67 and as high as $1.15. BIOR has an average analyst recommendation of Strong Buy. The company has an average price target of $6.00.

BIOR has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on BIOR!

See Full BIOR Report

Biora Therapeutics Inc has a Long-Term Technical rank of 58. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 42% of the market scoring higher. In the Biotechnology industry which is number 75 by this metric, BIOR ranks better than 75% of stocks.

Important Dates for Investors in BIOR:

-Biora Therapeutics Inc is set to release earnings on 11/13/2022. Over the last 12 months, the company has reported EPS of $-2.21. -We do not have a set dividend date for Biora Therapeutics Inc at this time. Click Here To Get The Full Report on Biora Therapeutics Inc (BIOR)